Abcellera Biologics Inc
NASDAQ:ABCL

Watchlist Manager
Abcellera Biologics Inc Logo
Abcellera Biologics Inc
NASDAQ:ABCL
Watchlist
Price: 2.915 USD -0.17% Market Closed
Market Cap: 861m USD
Have any thoughts about
Abcellera Biologics Inc?
Write Note

Abcellera Biologics Inc
Total Assets

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Abcellera Biologics Inc
Total Assets Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Total Assets CAGR 3Y CAGR 5Y CAGR 10Y
Abcellera Biologics Inc
NASDAQ:ABCL
Total Assets
$1.5B
CAGR 3-Years
14%
CAGR 5-Years
133%
CAGR 10-Years
N/A
Arch Biopartners Inc
XTSX:ARCH
Total Assets
CA$1.5m
CAGR 3-Years
-17%
CAGR 5-Years
10%
CAGR 10-Years
23%
Replicel Life Sciences Inc
XTSX:RP
Total Assets
CA$331.5k
CAGR 3-Years
-5%
CAGR 5-Years
23%
CAGR 10-Years
-20%
Innovotech Inc
XTSX:IOT
Total Assets
CA$1.4m
CAGR 3-Years
9%
CAGR 5-Years
39%
CAGR 10-Years
17%
No Stocks Found

Abcellera Biologics Inc
Glance View

Market Cap
847.8m USD
Industry
Life Sciences Tools & Services

AbCellera Biologics, Inc. engages in the development of therapeutic antibodies. The company is headquartered in Vancouver, British Columbia and currently employs 386 full-time employees. The company went IPO on 2020-12-11. AbCellera's full-stack, artificial intelligence (AI)-powered drug discovery platform integrates technologies from engineering, microfluidics, single-cell analysis, high-throughput genomics, machine learning, and hyper-scale data science. AbCellera partners with drug developers of all sizes, from large pharmaceutical to small biotechnology companies, enabling them to tackle the toughest problems in drug development.

ABCL Intrinsic Value
1.553 USD
Overvaluation 47%
Intrinsic Value
Price

See Also

What is Abcellera Biologics Inc's Total Assets?
Total Assets
1.5B USD

Based on the financial report for Dec 31, 2023, Abcellera Biologics Inc's Total Assets amounts to 1.5B USD.

What is Abcellera Biologics Inc's Total Assets growth rate?
Total Assets CAGR 5Y
133%

Over the last year, the Total Assets growth was -3%. The average annual Total Assets growth rates for Abcellera Biologics Inc have been 14% over the past three years , 133% over the past five years .

Back to Top